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Knockout of the inerleukin-18 (IL-18) gene predisposed mice to impaired clearance of neurovirulent influenza A virus-
infected neurons from the brain. In wild-type mice, IL-18 molecule-producing microglia/macrophages emerged in virally
attacked regions as early as day 3 after infection. Microglial transformation into macrophages culminated at day 7 to 9, with
upregulated expression of Iba1, a novel calcium-binding protein that controls phagocytic functions of microglia/macro-
phages. In IL-182/2 mice, microglial transformation was interrupted with reduced Iba1 expression. Interferon-g (IFN-g)-
immunopositive neurons appeared in and around virally invaded regions in wild-type mice, peaking in number at day 7,
whereas such cells were barely detected in IL-182/2 mice. Stereotaxic microinjection of recombinant IFN-g triggered
microglial transformation in IL-182/2 mice and upregulated Iba1 expression, leading to effective eradication of virally
infected neurons. Collectively, these results suggest that IL-18 plays a key role in activating microglial functions directed
against the influenza virus infection by inducing neuronal IFN-g in the brain parenchyma. © 2001 Academic Press









Interleukin-18 (IL-18), originally designated interferon-g
(IFN-g)-inducing factor, is a newly cloned pleiotropic cyto-
kine that is synthesized mainly by activated macrophages
(Okamura et al., 1998). IL-18 induces IFN-g production
through Th1 cells, NK cells, and B cells (Kohno et al., 1997;
kamura et al., 1995b; Yoshimoto et al., 1997). IL-12 upregu-
ates IL-18 receptor expression on T cells, Th1 cells, and B
ells and brings about synergistic effects with IL-18 on
FN-g production (Sareneva et al., 2000; Yoshimoto et al.,
998). IL-18 and interferon-a/b also synergize for IFN-g
gene expression in T cells (Sareneva et al., 1998). IL-18
enhances Fas ligand-mediated cytotoxicity of Th1 and NK
cells as well as perforin-mediated NK cell activity (Dao et
al., 1996; Hyodo et al., 1999; Tsutsui et al., 1996). Thus, IL-18,
in concert with other immunomodulatory molecules, may
play a significant role in amplifying cytotoxic activities
against unwanted cells, encompassing virally infected
cells. Interestingly, it has been shown that IL-18 is ex-
pressed in the mouse brain during early postnatal stages,
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163probably reflecting its developmental role in the central
nervous system (CNS) (Prinz and Hanisch, 1999). Cultured
microglial cells express IL-18 upon stimulation with lipo-
polysaccharide (Conti et al., 1999; Prinz and Hanisch, 1999).
However, there has been no evidence of expression of
IL-18 molecules in more mature brains, and it is still unclear
whether IL-18 is expressed in the brain upon exposure to a
certain insult, including viral infection of the CNS.
Influenza viruses have been associated with a broad
spectrum of CNS complications extending from acute
encephalitis/encephalopathy to neuropsychiatric disor-
ders (Mori and Kimura, 2001). Accumulating evidence
has suggested the potential neuroinvasiveness of influ-
enza viruses for humans (Frankova et al., 1977; Fujimoto
et al., 1998; Gamboa et al., 1974; Hakoda and Nakatani,
000; Murphy and Hawkes, 1970; Takahashi et al., 2000;
ogashi et al., 2000). However, knowledge is scarce
bout the immune mechanism that exterminates the vi-
us from the CNS as well as the immunopathology in-
uced by the virus; hence, no effective treatment has
een developed.
Here we describe the early expression of IL-18 mole-
ules in the mouse brain after neurovirulent influenza A
irus infection and the defense mechanism conferred by
his immunomudulatory cytokine, focusing especially0042-6822/01 $35.00
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164 MORI ET AL.upon microglial actions that serve as the first line of
defense against viral infections of the CNS.
RESULTS
Impaired elimination of the influenza WSN virus-
infected neurons in the brain of IL-182/2 mice
The influenza A/WSN/33 virus, introduced into the right
olfactory bulb of C57BL/6 mice, causes nonlethal acute
encephalitis in mice with a high propensity to infect
selectively restricted neurons in the brain parenchyma
(Mori et al., 1999). This phenomenon is reproduced in
this study. Thus, clusters of infected neurons appeared in
the anterior olfactory nucleus (AON), piriform cortex, ha-
benular and thalamic midline paraventricular nuclei, and
hypothalamus. The time course study showed that WSN
virus-immunopositive neurons emerged in the AON as
early as day 1 after infection (Fig. 1). Thereafter, the
infected neurons increased in number, peaking at day 5
in wild-type mice and at day 7 in IL-182/2 mice. At day
7, the larger number of virally infected neurons in IL-
182/2 mice than in wild-type mice was statistically sig-
nificant (P , 0.01 by Student’s t test). The infected
neurons were eliminated by day 14 in wild-type mice,
whereas a small number of WSN virus-immunopositive
degenerating neurons still remained in the brain of IL-
182/2 mice. We have recently unraveled the process by
which WSN virus-infected neurons die through apoptosis
in the brain of C57BL/6 mice (Mori and Kimura, 2000). At
day 7, the cresyl violet staining method disclosed that
most neurons in the virally attacked areas of IL-182/2
mice became shrunken, displaying peculiar nuclei (i.e.,
fragmented nuclei and condensed chromatin) as in the
case of wild-type mice, suggesting that the infected neu-
rons were dying through mechanisms associated with
FIG. 1. Kinetics in the number of WSN virus-immunolabeled neurons
in the ipsilateral AON of wild-type (black bars) and IL-182/2 mice (gray
bars) after microinjection of the virus into the right olfactory bulb.
Virus-infected cells were counted in the whole area of the section
preparation. Data are expressed as averages 6 SEM (n 5 3 for each
roup for each time point). *Statistically significant (P , 0.01) by
tudent’s t test.apoptosis (Mori and Kimura, 2000).Appearance of IL-18 molecules in the mouse brain
after the WSN virus infection
In virally attacked areas of the AON, IL-18-immunopo-
sitive cells emerged as early as day 3 after infection in
wild-type mice (Fig. 2). A small fraction of cells immu-
nopositive for IL-18 molecules displayed rod-shaped
morphology (Kreutzberg, 1996). Most IL-18-positive cells,
however, presented mixed morphological features of
both microglia and macrophages, i.e., large cellular size
(around 10 mm in diameter) and round or irregular cellu-
lar outline with processes (Figs. 3A and 3B). To identify
the IL-18-bearing cells, we immunostained brain tissues
doubly for IL-18 and Iba1, a novel EF-hand Ca21-binding
protein that is selectively expressed in cells belonging to
the monocyte/macrophage lineage including microglia
(Imai et al., 1996; Ito et al., 1998). The dual immunolabel-
ing unequivocally demonstrated that the IL-18-bearing
cells express Iba1 molecules, indicating that the cells
were identical to microglia/macrophages (Fig. 3B). In
other brain parenchymal regions where the virus infec-
tion did not reach, the immunohistochemistry did not
detect any IL-18 molecule-expressing cells. The time
course study showed that IL-18-bearing cells peaked in
number at day 3 after infection, substantially decreased
at day 5, and eventually disappeared by day 9 (Fig. 2).
Microinjection of UV-inactivated virus into the right olfac-
tory bulb did not induce IL-18-immunopositive cells in the
mouse brain. IL-18-immunopositive cells did not emerge
in the brain of IL-182/2 mice after infection with the
WSN virus at any time point tested.
Transformation of microglial cells into macrophages
In the previous study we found that resting microglia
transform themselves into an activated state of rod-
shaped cells in response to influenza virus infection
throughout the brain (Mori et al., 2000). Such activated
FIG. 2. Time course study of the number of IL-18 molecule-immu-
nopositive cells that appeared in the ipsilateral AON of wild-type mice.
IL-18 molecule-producing cells were counted in the whole area of the
section preparation. Data are expressed as averages 6 SEM (n 5 3









165IL-18 IN CONTROLLING CNS VIRUS INFECTIONmicroglia further transform themselves into macrophage-
like cells (i.e., microglia-derived brain macrophages) es-
pecially in virus-infected areas of the brain where in-
fected neurons are degenerating. In wild-type mice, sev-
eral Iba-immunopositive macrophages appeared in the
virally attacked regions of the AON at days 7 and 9 (Fig.
4). All those macrophages showed a strong Iba-1 immu-
noreactivity (Fig. 5A). In sharp contrast, Iba1-immunore-
active macrophages did not appear in the brain of IL-
182/2 mice throughout the course of infection. Only
rod-shaped or small round cells with faint Iba1 immuno-
reactivity emerged where infected neurons were present
(Fig. 5B).
Induction of IFN-g molecules in the mouse brain
Because IL-18 is a potent IFN-g inducer, we have
nvestigated the expression of IFN-g molecules in the
rain parenchyma after infection with the virus. In the
rain of wild-type mice, cells with IFN-g immunoreactivity
appeared as early as day 3 after infection, peaked in
number at day 7, and eventually vanished by day 12 (Fig.
6). Such IFN-g-bearing cells presented neuronal mor-
FIG. 3. IL-18-bearing cells observed in the virally invaded area of
displayed morphological features of microglia/macrophages. The bar
EF-hand calcium-binding protein that is expressed in microglia/mac
Iba1-specific signal (red) to produce the mixed confocal image (yellow)
eatures of microglia/macrophages. The arrowhead points to a small c
cell. The bar marker represents 10 mm.
FIG. 4. Appearance of brain macrophages with Iba immunoreactivity
n the virally attacked area of the ipsilateral AON in wild-type mice. Data
re expressed as averages 6 SEM (n 5 3 for each time point). aphology (Figs. 7A and 7B) and the dual immunolabeling
for IFN-g and neuron-specific enolase demonstrated that
hese IFN-g-producing cells were definitely neurons (Fig.
E). IFN-g immunoreactivity was detected mainly in the
N at day 3 after infection. (A) IL-18-immunolabeled cells (green) that
r represents 10 mm. (B) Overlapped image of IL-18 and Iba1, a novel
es. The IL-18-specific signal (green) was superimposed upon the
row indicates an IL-181/Iba11 cell that displayed mixed morphological
IL-182/Iba11 phenotype, most likely representing a resting microglial
FIG. 5. Microglial transformation into brain macrophages in re-
sponse to WSN virus infection. (A) A cluster of brain macrophages with
eminent Iba1 immunoreactivity found in the virally attacked area of the
AON of wild-type mice at day 7 after infection (arrows). (B) Rod-shaped
cells (arrowheads) intermixed with small round cells, displaying weak
Iba1 immunoreactivity, observed at day 7 in the virus-infected region of































































166 MORI ET AL.perikarya of neurons, but it was also observed in neu-
rites on occasion. Such IFN-g-producing neurons ap-
peared abundantly in virus-attacked areas of the brain
parenchyma (Fig. 7A), but they were also scattered in
tissues such as the tenia tecta where viral infection did
not reach (Fig. 7B). In sharp contrast to wild-type mice,
no cells immunopositive for IFN-g occurred in the brain
of IL-182/2 mice (Fig. 7C), suggesting the impaired
induction of IFN-g molecules in the CNS of these immu-
odefective mice.
nduction of microglial response by administering the
xogenous IFN-g into the brain of IL-182/2 mice
To confirm that impaired IFN-g expression in the brain
of IL-182/2 mice leads to interrupted microglial trans-
formation into brain macrophages, we directly adminis-
tered recombinant murine IFN-g into the AON and mon-
tored the appearance of brain macrophages and the
learance of virally infected neurons. Microinjection of
hosphate-buffered saline (PBS) into the AON did not
nfluence the level of microglial activation (Fig. 8A). Mi-
roinjection of 1 or 10 units of IFN-g into the AON in-
uced microglial transformation into macrophages with
trong Iba1 immunoreactivity only in the vicinity of the
eedle track (Fig. 8B). Furthermore, introduction of 100
nits of IFN-g into the AON induced brain macrophages
hat were widespread in the brain section ipsilaterally,
ncluding the AON and the frontal cortex (Fig. 8C). Upon
taining with cresyl violet, no significant neurodegenera-
ion was detected in the brain except the needle track
njury. Stereotaxic introduction of recombinant murine
FN-g into the right AON at day 5 after infection induced
ba1-immunopositive brain macrophages at day 7 (IFN-g
group, 11.0 6 2.0 for the AON area; PBS group, 0.3 6 0.3
or the AON area; P , 0.01 by Student’s t test; data are
FIG. 6. A time course study of the occurrence of cells with IFN-g
immunoreactivity in the ipsilateral AON of wild-type mice after infection
with the WSN virus. IFN-g-immunopositive cells were counted in the
hole area of the section preparation. Data are expressed as aver-
ges 6 SEM (n 5 3 for each time point).xpressed as averages 6 SEM, n 5 3 for each group) lreduced the number of virally infected neurons in the
ipsilateral AON at day 7 (IFN-g group, 11.7 6 0.3 for the
ON area; PBS group, 102.7 6 17.5 for the AON area; P ,
.05 by Student’s t test; data are expressed as aver-
ges 6 SEM, n 5 3 for each group) and eventually
radicated them by day 14.
DISCUSSION
IL-18 molecules appeared exclusively in microglia/
acrophages in the brain of C57BL/6 mice at the early
ime point of day 3 after infection. To our knowledge, this
s the first report describing IL-18 expression in micro-
lia/macrophages in response to infection of the CNS.
hese IL-18-producing microglia/macrophages emerged
trictly in virus-infected regions of the brain parenchyma,
lluding to this molecule’s possible role in amplifying the
mmune response. Expression of IL-18 was followed by
he induction of neuronal IFN-g and successively by
icroglial transformation into macrophages with upregu-
ated expression of Iba1 molecules. Knockout of the IL-18
ene led mice to a more widespread and prolonged
SN virus infection in the brain parenchyma in conjunc-
ion with impaired microglial activation.
Extensive evidence has suggested that microglia play
central role in the first line of defense in the CNS
Kreutzberg, 1996). Microglia are rapidly activated in re-
ponse to a certain insult given to the brain in a stereo-
yped and graded fashion (Kreutzberg, 1996). In the first
tage (the nonphagocytic state), resident resting micro-
lia become activated but do not become phagocytic. In
he second stage (the phagocytic state), activated micro-
lia further transform themselves into brain macro-
hages, if the insult to neurons is lethal. Intriguingly,
icroglial transformation into brain macrophages was
nterrupted in the brain of IL-182/2 mice, which may
ive a reasonable explanation to delayed clearance of
irally infected apoptotic neurons in these mice.
To address the mechanism of IL-18-dependent micro-
lial activation in the mouse brain, we have monitored
FN-g expression in the brain parenchyma after infection.
ontrary to expectation, neurons, rather than lympho-
ytes, exhibited conspicuous IFN-g immunolabeling.
Such IFN-g immunoreactivity might be identical to neu-
ronal IFN-g, which was originally purified from rat trigem-
inal ganglia by immunoaffinity chromatography and has
been well characterized in vitro (Olsson et al., 1994). Its
molecular weight is distinct from that of lymphocyte-
derived IFN-g, although these two molecules share
some important biological functions such as control of
cell proliferation, induction of the major histocompatibil-
ity complex class I and II, and antiviral effects. Neuronal
IFN-g immunoreactivity is selectively expressed in the
erikarya of neurons in the hypothalamic tuberomammil-




















167IL-18 IN CONTROLLING CNS VIRUS INFECTIONrat brain (Bentivoglio et al., 1994). Neuronal IFN-g ap-
ears in the cytoplasm of axotomized motor neurons,
nd upregulated expression of neuronal IFN-g is re-
orded in response to infection with Sendai and mumps
iruses in cultured sensory neurons (Eneroth et al., 1992;
lsson et al., 1989). Our results showed that no IFN-g
immunoreactivity was detected in the brain of IL-182/2
mice, which may explain the impaired microglial activa-
tion in these immunodefective mice. Direct administra-
tion of recombinant IFN-g into the brain of IL-182/2
mice triggered microglial transformation, upregulation of
Iba1 expression, and clearance of virally infected neu-
rons, demonstrating the importance of IFN-g in inducing
some important microglial functions directed against the
viral infection. Recently we showed that Iba1 molecules
are involved in membrane ruffling, and thus cell migra-
tion, and phagocytic functions of microglia/macrophages
(Ohsawa et al., 2000).
Biological actions of IFN-g in the CNS, mediated by
inducible nitric oxide synthetase-derived nitric oxide, can
be detrimental by expediting neuronal death leading to
neuropathology, while they can be beneficial by promot-
ing the differentiation and survival of neurons (Munoz-
Fernandez and Fresno, 1998). Accordingly, it appears
reasonable to speculate that IFN-g, produced in virus-
attacked areas, may facilitate cytotoxic and phagocytic
activities in order to exterminate virally infected neurons,
whereas that released in surrounding regions may pro-
vide neurons with direct antiviral actions and protective
supports for survival.
IL-18 production is downregulated on day 5 after in-
fection and later, suggesting that IL-18 expression is
strictly controlled in the brain. Prolonged and uncon-
trolled expression of IL-18 may give rise to intensified
inflammation and tissue damage (Okamura et al., 1995a).
On the other hand, IL-18 may offer a promising prophy-
lactic and therapeutic strategy against intracellular mi-
crobes (Fujioka et al., 1999; Mastroeni et al., 1999; Oh-
kusu et al., 2000; Sugawara et al., 1999; Tanaka-Kataoka
FIG. 7. Neurons with IFN-g immunoreactivity that emerged in the
immunolabeled neurons observed (A) in the piriform cortex where a num
did not reach. Seven days after infection. Note that neurites as wel
mmunopositive neurons did not appear (C) in the AON of IL-182/2 m
nfection. The bar marker in (D) represents 10 mm and applies to (A)
enolase. The IFN-g-specific signal (red) was superimposed upon neur
arrows indicate IFN-g-positive neurons in the virus-attacked region of
mm.
FIG. 8. Induction of microglial transformation into brain macrophages
esponse was obtained by stereotaxically administering 1 ml of PBS into
were observed near the needle track injury (indicated by the asterisk).
only in the vicinity of the needle track injury (indicated by the asterisk)
ON. (C) When mice were given 100 units of IFN-g in the right AON
widespread in the brain section ipsilaterally, including the AON, as sho
of the brain was not evident 48 h after introduction of 100 units of IFN-
were observed. The bar marker represents 10 mm and applies to (A) throughet al., 1999). The pharmacological effects of this cytokine
on influenza virus-induced encephalitis remain to be
investigated in our experimental system.
MATERIALS AND METHODS
Experimental infection of animals
Specific pathogen-free female C57BL/6J mice (Clea
Japan, Osaka, Japan), 4 weeks of age, were used for
experiments. IL-182/2 mice, with a genetic background
of C57BL/6 mice, were generated by the gene targeting
method (Takeda et al., 1998) and were bred in The Ani-
mal Laboratory of Fukui Medical University. Female IL-
182/2 mice were used for experiments at the age of 4
weeks. One microliter of the suspension containing 105
plaque-forming units of the influenza A/WSN/33 virus (a
kind gift from Dr. S. Nakajima, The Institute of Public
Health, Tokyo, Japan) was stereotaxically introduced into
the right main olfactory bulb as described previously
(Mori et al., 1999).
UV inactivation of the virus
Stock virus was inactivated with UV light as described
previously (Mori et al., 1995). The titer of infectious influ-
nza virus particles was reduced to ,1027 of the original.
issue processing
Under deep anesthesia from the intraperitoneal ad-
inistration of 7.2% chloral hydrate in PBS (0.05 ml/g
ody weight), mice were perfused with ice-cold 3.7%
ormaldehyde in PBS. The brains were dissected free of
he cranium, soaked in 15% sucrose in PBS at 4°C
vernight, and frozen at 280°C. Coronal sections of
4-mm thickness were cut on a cryostat at levels encom-
assing the AON and habenular/paraventricular nucleus,
ir-dried, and kept at 230°C until staining.
of wild-type mice in response to the WSN virus infection. IFN-g-
neurons became infected and (B) in the tenia tecta where viral infection
toplasm of these neurons displayed IFN-g immunoreactivity. IFN-g-
day 7 after infection and (D) in the AON of wild-type mice after mock
h (D). (E) IFN-g-producing cells with coexpression of neuron-specific
cific signal (green) to produce the mixed confocal image (yellow). The
othalamus. Seven days after infection. The bar marker represents 10
genous murine IFN-g in the brain of IL-182/2 mice. (A) No microglial
ht AON. Resting microglia with faint Iba1 immunolabeling (arrowheads)
in macrophages with strong Iba1 immunoreactivity (arrows) emerged
er microinjection of 1 or 10 units of recombinant murine IFN-g into the
-bearing brain macrophages (arrows) appeared 48 h after injection,
e figure, and the frontal cortex. (D) Microglial activation in the left side





























169IL-18 IN CONTROLLING CNS VIRUS INFECTIONIn situ immunolabeling
In situ single or dual immunolabeling of WSN virus
antigens and various molecules in the brain slices was
performed according to the protocol previously de-
scribed (Mori et al., 1999, 2000) with the use of rabbit
anti-WSN virus serum (a generous gift from Dr. S. Naka-
jima, The Institute for Public Health, Tokyo, Japan), rat
monoclonal antibody against mouse IL-18 (clone 39-3F,
IgG2ax; working concentration, 1.5 mg/ml), affinity-puri-
ied rabbit anti-Iba-1 antibody (working concentration 2.0
mg/ml), rat monoclonal antibody against murine IFN-g
(PBL Biomedical Laboratories, New Brunswick, NJ; clone
RMMG-1; working concentration, 6.25 mg/ml), and
mouse monoclonal antibody against neuron-specific
enolase (Chemicon International, Temecula, CA;
MAB324; working concentration, 9 mg/ml). The intestinal
tissue of a mouse was used as a positive control for IL-18
molecules (Takeuchi et al., 1997). Negative controls in-
cluded the normal brain and sham-staining without the
primary antibody. The immunolabeling was visualized
under the Olympus GB200-UV-H-SET confocal laser
scanning microscope (Olympus Optical Co. Ltd., Tokyo,
Japan) at an excitation wavelength of 488 nm. An adja-
cent series of sections was stained with cresyl violet for
histopathological and cytoarchitectonic observation as
well as for detection of morphological alterations char-
acteristic of apoptosis.
Stereotaxic microinjection of recombinant murine
IFN-g into the brain
Mice were anesthetized with 7.2% chloral hydrate in
BS (0.005 ml/g body weight) and immobilized in a ste-
eotaxic frame. The stereotaxic coordinates relative to
he bregma were 2.6 mm rostral, 0.9 mm right lateral, and
.0 mm ventral. A 1-ml suspension of recombinant mu-
rine IFN-g (Life Technologies, Gaithersburg, MD), con-
taining 0, 1, 10, or 100 units in PBS, was injected into the
right AON with a Hamilton syringe at a rate of 0.5 ml/min.
The needle was retained in situ for a further 5 min after
injection.
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